ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

CMS Withholds Coverage of CT Colonography

May 15, 2009

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

Three CBCCPs Say They’ll Appeal To NC On Termination

March 21, 1980